Shelly Xiao

Analyst丨Investment Banking at Hollyhigh International Capital

Shelly Xiao 肖莉丨Analyst丨Investment Banking

Hollyhigh International Capital 东方高圣 上海茂名南路59号老锦江饭店贵宾楼5EF 5EF,Jinjiang Hotel,No 59,South Maoming Road,Shanghai,200020

We chat：xiaolimlm

Shelly Xiao
Contact
xiaoli@hollyhigh.cn

Recent transactions

Transactions
BRM421
Grandpharma
GrandPharm obtained the right to commercialize BRM421,a new drug for dry eye syndrome, in mainland China, HK and Macau.
logo
Advisor to the seller :
Hollyhigh International Capital
Tocagen Inc.
ApolloBio Corp.
Tocagen and ApolloBio Enter License Agreement to Develop and Commercialize Toca 511 & Toca FC in China Region
logo
Advisor to the buyer :
Hollyhigh International Capital
Inovio Pharmaceuticals Inc.
ApolloBio Corp.
License and Collaboration Agreement with ApolloBio Corp to Develop and Commercialize VGX-3100 in Greater China
logo
Advisor to the seller :
Hollyhigh International Capital

REACH Cross-border Mergers and Acquisitions is a worldwide partnership consisting of 24 M&A advisory firms operating across 31 countries.

REACH Cross-Border Mergers & Acquisitions Logo with tagline Terms & Conditions
Privacy Policy

© 2025 REACH Cross-border Mergers and Acquisitions